JT, Nissin to acquire Katokichi to integrate frozen food businesses

JT, Nissin to acquire Katokichi to integrate frozen food businesses

TOKYO, Japan - Japan Tobacco Inc. President Hiroshi Kimura (L), frozen food firm Katokichi Co. President Tetsuji Kanamori (C) and instant noodle maker Nissin Food Products Co. President Koki Ando (R) hold a press conference in Tokyo on Nov. 22. Japan Tobacco and Nissin have agreed to acquire Katokichi to create one of Japan's largest frozen food businesses with combined sales of 260 billion yen.

  • Product Code
  • ILEA001125056
  • Registered date
  • 2007/11/22 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2007 Kyodo News
  • Media size
  • 1864 × 1162 pixel
  • Resolution
  • dpi
  • Deployment size
  • 649.41(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Nissan logs 221.92 bil. yen net loss in April-Sept.

    Nissan logs 221.92 bil. yen net loss in April-Sept.

    Nissan Motor Co. CEO Ivan Espinosa speaks at a press conference in Yokohama near Tokyo on Nov. 6, 2025. Nissan reported a net loss of 221.92 billion yen ($1.44 billion) for the April-September period on sluggish global vehicle sales and the impact of hefty U.S. tariffs.
      Japan's MUFG Bank head Hanzawa

      Japan's MUFG Bank head Hanzawa

      MUFG Bank President Junichi Hanzawa (C) speaks at a press conference in Tokyo on Dec. 16, 2024. He apologized over the alleged theft of more than 1 billion yen ($6.5 million) by a former employee from customers' safe deposit boxes at the Japanese megabank.
        Scandal-ridden Bigmotor reborn as new firm

        Scandal-ridden Bigmotor reborn as new firm

        Shinjiro Tanaka (R), president of Wecars, a new firm that took over the troubled used car dealership Bigmotor Co.'s main businesses, attends a press conference in Tokyo on May 1, 2024. The president vowed to make Wecars' operations transparent following the high-profile insurance fraud scandal, as it runs about 250 outlets with a workforce of 4,200.

          Scandal-ridden Bigmotor reborn as new firm

          TOKYO, Japan, May 1 Kyodo - Shinjiro Tanaka (C), president of Wecars, a new firm that took over the troubled used car dealership Bigmotor Co.'s main businesses, poses at a press conference in Tokyo on May 1, 2024. The president vowed to make Wecars' operations transparent following the high-profile insurance fraud scandal, as it runs about 250 outlets with a workforce of 4,200. (Kyodo)
            Chugoku Electric Power Co. president to resign

            Chugoku Electric Power Co. president to resign

            Chugoku Electric President Natsuhiko Takimoto announces his resignation in a press conference in the western Japan city of Hiroshima on March 30, 2023, to take responsibility for a cartel case over electricity sales. The Japan Fair Trade Commission ordered three major utilities, including Chugoku Electric, to pay a total of 101 billion yen ($763 million) in fines, the highest ever imposed by the antitrust watchdog.
              Chugoku Electric Power Co. President to resign

              Chugoku Electric Power Co. President to resign

              Chugoku Electric President Natsuhiko Takimoto (C) announces his resignation in a press conference in the western Japan city of Hiroshima on March 30, 2023, to take responsibility for a cartel case over electricity sales. The Japan Fair Trade Commission ordered three major utilities, including Chugoku Electric, to pay a total of 101 billion yen ($763 million) in fines, the highest ever imposed by the antitrust watchdog.
                U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                    Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                      Rakuten, Japan Post in capital tie-up

                      Rakuten, Japan Post in capital tie-up

                      Japanese e-commerce giant Rakuten Inc. Chairman and CEO Hiroshi Mikitani (L) and Japan Post Holdings Co. President and CEO Hiroya Masuda hold a joint press conference in Tokyo on March 12, 2021. The two companies said the same day Rakuten will sell an 8.32 percent stake to Japan Post for about 150 billion yen ($1.38 billion).